143 related articles for article (PubMed ID: 36385804)
1. Preparation and Characterization of Aprepitant Solid Dispersion with HPMCAS-LF.
Liu J; Li Y; Ao W; Xiao Y; Bai M; Li S
ACS Omega; 2022 Nov; 7(44):39907-39912. PubMed ID: 36385804
[TBL] [Abstract][Full Text] [Related]
2. Design and Characterization of Phosphatidylcholine-Based Solid Dispersions of Aprepitant for Enhanced Solubility and Dissolution.
Yeo S; An J; Park C; Kim D; Lee J
Pharmaceutics; 2020 Apr; 12(5):. PubMed ID: 32365589
[TBL] [Abstract][Full Text] [Related]
3. Amorphous solid dispersion preparation via coprecipitation improves the dissolution, oral bioavailability, and intestinal health enhancement properties of magnolol.
Cao J; Zhang S; Hao Y; Fan K; Wang L; Zhao X; He X
Poult Sci; 2023 Jun; 102(6):102676. PubMed ID: 37104903
[TBL] [Abstract][Full Text] [Related]
4. Characterization and Pharmacokinetic Study of Aprepitant Solid Dispersions with Soluplus®.
Liu J; Zou M; Piao H; Liu Y; Tang B; Gao Y; Ma N; Cheng G
Molecules; 2015 Jun; 20(6):11345-56. PubMed ID: 26102068
[TBL] [Abstract][Full Text] [Related]
5. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.
Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
Pharm Res; 2008 Mar; 25(3):563-77. PubMed ID: 17828444
[TBL] [Abstract][Full Text] [Related]
6. [Effect of HPMCAS/curcumin amorphous solid dispersion in enhancing dissolution and chemical stability of curcumin].
Liang Q; Wang YR; Deng YY
Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(15):3305-3311. PubMed ID: 31602887
[TBL] [Abstract][Full Text] [Related]
7. Development of a Ternary Solid Dispersion Formulation of LW6 to Improve the In Vivo Activity as a BCRP Inhibitor: Preparation and In Vitro/In Vivo Characterization.
Bajracharya R; Lee SH; Song JG; Kim M; Lee K; Han HK
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31052438
[TBL] [Abstract][Full Text] [Related]
8. Enteric and hydrophilic polymers enhance dissolution and absorption of poorly soluble acidic drugs based on micro-environmental pH-modifying solid dispersion.
Zhang S; Xu X; Sun W; Zhang Z; Pan B; Hu Q
Eur J Pharm Sci; 2022 Jan; 168():106074. PubMed ID: 34798261
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast.
Madan JR; Pawar AR; Patil RB; Awasthi R; Dua K
Polim Med; 2018; 48(1):17-24. PubMed ID: 30657654
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of Metformin Hydrochloride - Compritol 888 ATO Solid Dispersion.
Jagdale S; Patil S; Kuchekar B; Chabukswar A
J Young Pharm; 2011 Jul; 3(3):197-204. PubMed ID: 21897658
[TBL] [Abstract][Full Text] [Related]
11. Development of solid dispersion systems of dapivirine to enhance its solubility.
Gorajana A; Ying CC; Shuang Y; Fong P; Tan Z; Gupta J; Talekar M; Sharma M; Garg S
Curr Drug Deliv; 2013 Jun; 10(3):309-16. PubMed ID: 23360246
[TBL] [Abstract][Full Text] [Related]
12. Application of Solid Dispersion Technique to Improve Solubility and Sustain Release of Emamectin Benzoate.
Huang BB; Liu DX; Liu K; Wu G
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779169
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
14. Development, characterization and solubility study of solid dispersions of Cefuroxime Axetil by the solvent evaporation method.
Arora SC; Sharma PK; Irchhaiya R; Khatkar A; Singh N; Gagoria J
J Adv Pharm Technol Res; 2010 Jul; 1(3):326-9. PubMed ID: 22247865
[TBL] [Abstract][Full Text] [Related]
15. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
16. An Approach to Enhance Dissolution Rate of Tamoxifen Citrate.
SreeHarsha N; Hiremath JG; Chilukuri S; Aitha RK; Al-Dhubiab BE; Venugopala KN; Alzahrani AM; Meravanige G
Biomed Res Int; 2019; 2019():2161348. PubMed ID: 30800663
[TBL] [Abstract][Full Text] [Related]
17. Solid-state characterization of lacidipine/PVP K(29/32) solid dispersion primed by solvent co-evaporation.
Mukharya A; Chaudhary S; Mansuri N; Misra AK
Int J Pharm Investig; 2012 Apr; 2(2):90-6. PubMed ID: 23119238
[TBL] [Abstract][Full Text] [Related]
18. Solubility and Permeability Enhancement of Oleanolic Acid by Solid Dispersion in Poloxamers and γ-CD.
De Stefani C; Lodovichi J; Albonetti L; Salvatici MC; Quintela JC; Bilia AR; Bergonzi MC
Molecules; 2022 May; 27(9):. PubMed ID: 35566392
[TBL] [Abstract][Full Text] [Related]
19. Effects of Polymers on the Drug Solubility and Dissolution Enhancement of Poorly Water-Soluble Rivaroxaban.
Choi MJ; Woo MR; Choi HG; Jin SG
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012748
[TBL] [Abstract][Full Text] [Related]
20. Physical properties and solubility studies of Nifedipine-PEG 1450/HPMCAS-HF solid dispersions.
Haware RV; Vinjamuri BP; Gavireddi M; Dave VS; Gupta D; Chougule MB; Stagner WC
Pharm Dev Technol; 2019 Jun; 24(5):550-559. PubMed ID: 30175691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
